JPRN-UMIN000033594已完成未知
Investigation of post-treatment after immune checkpoint inhibitor treatment for advanced or recurrent non-small cell lung cancer - Investigation of post-treatment after immune checkpoint inhibitor treatment for advanced or recurrent non-small cell lung cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 37
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patient, or family refuses to participate in the study
研究者
相似试验
招募中
Unknown
Evaluation of treatment response for immune checkpoint inhibitors in non-small cell lung cancer patients using [18F]F-AraG PET/CTlung cancerJPRN-jRCTs051220109akamoto Yuji60
进行中（未招募）
1 期
Evaluation of immunological response following a revaccination with a non-conjugated pneumococcal vaccine boosted or not by a conjugated pneumococcal vaccine in splenectomised patients (SPLENEVAC-2)Asplenic patients at risk for invasive pneumococcal diseasesMedDRA version: 20.0Level: PTClassification code 10041642Term: SplenectomySystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2018-003068-29-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)56
招募中
不适用
CIMAvax-EGF in different maintenance schemeson small cell lung cancerCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesNSCLCRPCEC00000368Center of Molecular Immunology (CIM)42
已完成
4 期
Assessment of Immune Modulation after use of NANO SOMACTRI/2021/10/037180DrPRRaghavan26
已完成
不适用
A prospective observational study of immune-checkpoint inhibitor (Nivolumab) treatment in patients with non-small cell lung canceron-small cell lung cancerJPRN-UMIN000021600Kitasato University School of Medicine52